Wedbush Keeps Their Buy Rating on Williams-Sonoma (WSM)
TD Cowen Maintains Buy on Williams-Sonoma, Adjusts Price Target To $170 (2-1 Stock Split)
Williams-Sonoma Analyst Ratings
Carlisle Companies Analyst Ratings
Lennox Intl Analyst Ratings
TD Cowen Remains a Buy on Williams-Sonoma (WSM)
BioMarin Pharmaceutical (BMRN) Receives a Buy From Piper Sandler
Maintaining Hold on Reliance Steel Amid Market Headwinds and Adjusted Financial Projections
Williams-Sonoma Analyst Ratings
Telsey Advisory Group Maintains Outperform on Williams-Sonoma, Lowers Price Target to $170
Telsey Advisory Sticks to Their Buy Rating for Williams-Sonoma (WSM)
Citi Upgrades Illumina, Quest, Agilent to Buy, Downgrades Avantor
10x Genomics Stock Slides 14% Amid Illumina Deal, Deutsche Downgrade
Goldman Sachs Maintains Buy on Lennox Intl, Raises Price Target to $575
Lennox Intl Analyst Ratings
Stephens & Co. Reiterates Overweight on Illumina, Maintains $170 Price Target
Illumina Analyst Ratings
Wells Fargo Downgrades Lennox International to Equalweight From Overweight, Price Target at $570
Morgan Stanley Keeps Their Hold Rating on Williams-Sonoma (WSM)
Barclays Remains a Hold on Lennox International (LII)